Wallis–Zieff–Goldblatt syndrome

From WikiMD's WELLNESSPEDIA

Wallis–Zieff–Goldblatt syndrome
Autosomal dominant - en.svg
Wallis–Zieff–Goldblatt syndrome has an autosomal dominant pattern of inheritance.




















Wallis–Zieff–Goldblatt syndrome is a rare condition characterized by inherited skeletal disorders manifested mainly as rhizomelic short stature and lateral clavicular defects.[1] It is also known as Cleidorhizomelic syndrome.[2]

Presentation[edit]

An initial clinical report of this syndrome describes a 6-month-old boy with rhizomelic shortening, particularly in the arms, and protuberances over the lateral aspects of the clavicles. On radiographs the lateral third of the clavicles had a bifid appearance resulting from an abnormal process or protuberance arising from the fusion center. His 22-year-old mother also had a height of 142 cm with an arm span of 136 cm and rhizomelic shortness of the limbs, maximal in the arms, and abnormalities of the acromioclavicular joints. Both the mother and the son had marked bilateral clinodactyly of the fifth fingers associated with hypoplastic middle phalanx.[1]

Cause[edit]


Diagnosis[edit]

Treatment[edit]


References[edit]

  1. 1.0 1.1 "Newly recognized autosomal dominant syndrome of rhizomelic shortness with clavicular defect".Am J Med Genet.1988;31(4)
    881–5.doi:10.1002/ajmg.1320310422.PMID:3239579.
  2. Online Mendelian Inheritance in Man (OMIM) Cleidorhizomelic syndrome -119650

External links[edit]



WikiMD logo

This article is a stub

You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories.

Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia.


Wallis–Zieff–Goldblatt syndrome[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.